Top Pharma Companies in India by Market Cap

BSE Sensex 74718.15 140.84 (-0.19%)

Filter

Top Pharma Companies in India as on Sep-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
91	Solara Active Pharma Sciences Ltd.	Q V PT	3,574 Small Cap	751.40 (-0.69%)	N/A	2.87	-3.27	-145.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
92	Indraprastha Medical Corporation Ltd.	Q V PT	3,326 Small Cap	365.55 (-0.44%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
93	Ind-Swift Laboratories Ltd.	Q V+ PT	3,245 Small Cap	412.15 (8.02%)	57.88	2.22	-6.35	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
94	Advanced Enzyme Technologies Ltd.	Q V PT	3,227 Small Cap	296 (0.70%)	41.06	4.55	9.82	13.51	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
95	Hikal Ltd.	Q V+ PT	2,788 Small Cap	229.30 (0.07%)	N/A	2.37	-0.09	-53.23	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
96	Vimta Labs Ltd.	Q V+ PT	2,695 Small Cap	611.50 (-0.78%)	34.58	5.85	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
97	Dishman Carbogen Amcis Ltd.	Q V+ PT	2,672 Small Cap	170.20 (-0.06%)	165.22	0.4	5.82	-33.01	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
98	KMC Speciality Hospitals (India) Ltd.	Q V+ PT	2,453 Small Cap	163.40 (1.84%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
99	Dr Agarwals Eye Hospital Ltd.	Q V PT	2,598 Small Cap	5,339.95 (1.41%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
100	Shukra Pharmaceuticals Ltd.	Q V+ PT	2,467 Small Cap	57.25 (3.64%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
101	Indoco Remedies Ltd.	Q V+ PT	2,302 Small Cap	257.05 (0.10%)	421.02	2.37	8.25	-199.84	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
102	Windlas Biotech Ltd.	Q V+ PT	2,285 Small Cap	1,117.25 (-1.12%)	35.08	4.53	16.15	12.78	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
103	Panacea Biotec Ltd.	Q V+ PT	2,254 Small Cap	385 (2.43%)	N/A	2.75	0.55	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
104	Fischer Medical Ventures Ltd.	Q V PT	2,320 Small Cap	33.23 (1.10%)	77	4.93	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
105	Fredun Pharmaceuticals Ltd.	Q V+ PT	2,195 Small Cap	1,403.10 (4.12%)	51.69	7.71	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
106	Sai Parenterals Ltd.	Q V PT	2,257 Small Cap	507.95 (-0.62%)	136.82	2.89	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
107	Venus Remedies Ltd.	Q V+ PT	2,125 Small Cap	1,610.65 (1.05%)	18.34	3.1	7.02	18.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
108	Syncom Formulations (India) Ltd.	Q V+ PT	1,882 Small Cap	20.85 (5.30%)	21.76	4.23	20.39	30.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
109	Hester Biosciences Ltd.	Q V PT	1,861 Small Cap	2,190.75 (0.20%)	13.66	4.09	9.19	6.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
110	Suraksha Diagnostic Ltd.	Q V PT	1,750 Small Cap	352.10 (0.70%)	50.87	7.1	17.26	-44.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
111	Tarsons Products Ltd.	Q V PT	1,631 Small Cap	334.45 (-1.63%)	163.05	2.86	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
112	Krsnaa Diagnostics Ltd.	Q V+ PT	1,757 Small Cap	561.85 (1.20%)	18.48	1.82	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
113	NGL Fine-Chem Ltd.	Q V PT	1,716 Small Cap	2,713.20 (-0.63%)	29.49	4.85	14.19	-3.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
114	Jagsonpal Pharmaceuticals Ltd.	Q V+ PT	1,504 Small Cap	226.75 (-0.13%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
115	Shalby Ltd.	Q V+ PT	1,489 Small Cap	141.25 (1.95%)	38.07	1.47	21.51	-5.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
116	Gujarat Kidney And Super Speciality Ltd.	Q V PT	1,432 Small Cap	176.90 (-3.41%)	91.19	5.6	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
117	Amrutanjan Health Care Ltd.	Q V+ PT	1,427 Small Cap	501.20 (1.16%)	26.54	3.82	8.59	1.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
118	Anlon Healthcare Ltd.	Q V+ PT	1,219 Small Cap	29.04 (10.00%)	49.21	4.81	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
119	Fermenta Biotech Ltd.	Q V PT	1,400 Small Cap	474 (-0.06%)	23.08	3.38	6.85	5.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
120	Kopran Ltd.	Q V+ PT	1,342 Small Cap	273.20 (-3.48%)	54.75	2.55	6.74	-8.11	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anlon Healthcare	29.04	10%
Ind-Swift Labs.	412.15	8.02%
Aarti Pharmalabs	901	6.44%
Syncom Formulations	20.85	5.30%
Kilitch Drugs(India)	213.20	5%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Kopran	273.20	-3.48%
Guj. Kidney & Super	176.90	-3.41%
Kwality Pharma	3,709	-3.33%
Acutaas Chemicals	3,314.50	-3.15%
Concord Biotech	1,543.15	-2.38%

News about Top Pharma Companies in India

Sep, 2026

Fredun Pharmaceuticals informs about press release

Fredun Pharmaceuticals has informed that it enclosed press release titled ‘Fredun Pharmaceuticals Acquires 26% Stake in ?300 Crore-Valued Goodman Vetcare Pvt. Ltd., One of India’s Longest-Standing Dedicated Pet Pharmacies’ issued by the company.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Anlon Healthcare incorporates subsidiary in Nigeria

This subsidiary will provide access to 16 Western African Countries via its local entity

Sep, 2026

Anlon Healthcare informs about incorporation of subsidiary

Pursuant to regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (‘SEBI Master Circular’), Anlon Healthcare has informed that ‘ANLON HEALTHCARE NIGERIA’ having Registration Number ‘9874492’ has been incorporated as a subsidiary of the Company, with effect from September 20, 2026. The relevant details pursuant to Schedule III of the Listing Regulations and additional details as required under the SEBI Master Circular for compliance with the provisions of the Listing Regulations by listed entities is annexed in Annexure - A.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Krsnaa Diagnostics informs about updates

Krsnaa Diagnostics has informed regarding the voting results as the outcome of the postal ballot dated September 17, 2026.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Krsnaa Diagnostics informs about voting results of postal ballot and scrutinizer report

With reference to its letter no. KDL/SE/032/2026-27 dated August 18, 2026, Krsnaa Diagnostics has informed that it enclosed the Postal Ballot Notice dated August 13, 2026 (‘Notice’) for seeking approval of the shareholders of the Company on special resolution: Approval for Issuance of up to 16,21,000 Warrants Convertible into Equity Shares of Face Value Rs.5/- each on a Preferential Basis to the Promoter and Promoter Group of the Company. Pursuant to Sections 108, 110 and other applicable provisions, if any, of the Companies Act, 2013 (‘the Act’) read with the Companies (Management and Administration) Rules, 2014, guidelines prescribed by the Ministry of Corporate Affairs through various Circular(s) and the Listing Regulations, as amended from time to time, the Postal Ballot was conducted through remote e-voting process. The remote e-voting process concluded on Thursday, September 17, 2026, at 17:00 Hrs. (IST), post which Dinesh Shivnarayan Birla (Membership No.: FCS-7658, COP: 13029), Practicing Company Secretary and Proprietor of Dinesh Birla & Associates, Company Secretaries, Scrutinizer submitted the Report on the Postal Ballot voting results on September 18, 2026. Based on the Scrutinizer’s Report, the company has informed that the Special Resolution mentioned in the Postal Ballot Notice dated August 13, 2026 has been passed by the Members of the Company with requisite majority on September 17, 2026, i.e., the last date of remote e-voting. In connection with the above, it has enclosed the following: a. Voting results pursuant to Regulation 44(3) of the Listing Regulations and Section 108 of the Act read with the Companies (Management and Administration) Rules, 2014; and b. Scrutinizer's Report dated September 18, 2026 on remote e-voting.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Indoco Remedies gets nod to incorporate wholly owned subsidiary

The committee of executive directors of the company in its meeting held on September 18, 2026 has considered and approved the same

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Sun Pharmaceutical Industries Ltd.	4,40,398 Crore
2	Divis Laboratories Ltd.	2,48,664 Crore
3	Torrent Pharmaceuticals Ltd.	1,82,738 Crore
4	Apollo Hospitals Enterprise Ltd.	1,26,103 Crore
5	Zydus Lifesciences Ltd.	1,15,012 Crore
6	Cipla Ltd.	1,10,794 Crore
7	Laurus Labs Ltd.	1,05,645 Crore
8	Max Healthcare Institute Ltd.	1,02,684 Crore
9	Mankind Pharma Ltd.	95,744 Crore
10	Dr. Reddys Laboratories Ltd.	97,749 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,170	57,954	35.89	11.20	24.65	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,950	1,82,738	83.79	20.36	38.34	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,461	67,169	37.36	6.13	12.46	27.89
Lupin Ltd. (M)	Somewhat Good	2,127	98,070	17.74	4.12	9.82	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,505	44,562	39.27	9.17	26.53	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,026	1,05,645	117
Sai Life Sciences Ltd. (S)	Somewhat Good	1,607	34,003	76.91
Aurobindo Pharma Ltd. (M)	Very Good	1,702	99,828	53.55
Divis Laboratories Ltd. (L)	Very Good	9,413	2,48,664	52.16
Gland Pharma Ltd. (M)	Very Good	2,940	48,875	45.50
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,607	34,003	94.00	13.32	48.48	23.61
Mankind Pharma Ltd. (M)	Very Good	2,463	95,744	46.87	5.69	24.40	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,505	44,562	39.27	9.17	26.53	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,172	1,15,012	25.48	4.27	14.28	13.52
Gland Pharma Ltd. (M)	Very Good	2,940	48,875	43.30	4.60	22.09	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,607	34,003	94.00	13.32	48.48	39.96
Lupin Ltd. (M)	Somewhat Good	2,127	98,070	17.74	4.12	9.82	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,461	67,169	37.36	6.13	12.46	22.19
Abbott India Ltd. (M)	Very Good	27,170	57,954	35.89	11.20	24.65	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,215	97,749	30.34	2.56	15.56	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Fredun Pharmaceuticals informs about press release

Anlon Healthcare incorporates subsidiary in Nigeria

Anlon Healthcare informs about incorporation of subsidiary

Krsnaa Diagnostics informs about updates

Krsnaa Diagnostics informs about voting results of postal ballot and scrutinizer report

Indoco Remedies gets nod to incorporate wholly owned subsidiary

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?